 Peter Dempsey
Concepts (666)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 26 | 2015 | 59 | 3.000 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 80 | 2.150 |
Why?
| | Membrane Proteins | 20 | 2022 | 1119 | 1.680 |
Why?
| | Cell Plasticity | 3 | 2025 | 27 | 1.550 |
Why?
| | Intestines | 7 | 2023 | 350 | 1.550 |
Why?
| | ADAM10 Protein | 15 | 2022 | 30 | 1.390 |
Why?
| | Stem Cell Niche | 3 | 2021 | 53 | 1.320 |
Why?
| | ErbB Receptors | 28 | 2018 | 605 | 1.300 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 57 | 1.290 |
Why?
| | Intercellular Signaling Peptides and Proteins | 15 | 2013 | 373 | 1.240 |
Why?
| | Metalloendopeptidases | 14 | 2017 | 60 | 1.210 |
Why?
| | Receptors, Notch | 3 | 2020 | 84 | 1.170 |
Why?
| | Protein Precursors | 8 | 2010 | 128 | 1.100 |
Why?
| | Breast Neoplasms | 27 | 2014 | 2104 | 1.080 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 12 | 0.950 |
Why?
| | Integrases | 2 | 2018 | 119 | 0.900 |
Why?
| | Intestinal Mucosa | 9 | 2025 | 593 | 0.890 |
Why?
| | Organoids | 9 | 2024 | 104 | 0.880 |
Why?
| | Mammography | 17 | 2010 | 146 | 0.810 |
Why?
| | Breast | 11 | 2010 | 140 | 0.770 |
Why?
| | Paneth Cells | 3 | 2018 | 16 | 0.750 |
Why?
| | Biopsy, Needle | 8 | 2010 | 187 | 0.720 |
Why?
| | ADAM17 Protein | 18 | 2022 | 33 | 0.670 |
Why?
| | Regeneration | 4 | 2025 | 182 | 0.650 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 28 | 0.650 |
Why?
| | alpha-Defensins | 1 | 2018 | 10 | 0.620 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 26 | 0.610 |
Why?
| | Cell Membrane | 10 | 2017 | 734 | 0.580 |
Why?
| | Signal Transduction | 25 | 2018 | 4935 | 0.580 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 170 | 0.540 |
Why?
| | Proteolysis | 1 | 2017 | 167 | 0.530 |
Why?
| | Carcinogenesis | 2 | 2018 | 214 | 0.520 |
Why?
| | Breast Diseases | 4 | 2010 | 22 | 0.480 |
Why?
| | Animals | 71 | 2025 | 35409 | 0.480 |
Why?
| | Mice | 45 | 2025 | 16983 | 0.470 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 99 | 0.470 |
Why?
| | Epithelial Cells | 12 | 2025 | 1063 | 0.460 |
Why?
| | Growth Substances | 7 | 2001 | 148 | 0.450 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 47 | 0.430 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1205 | 0.420 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 187 | 0.420 |
Why?
| | Metalloproteases | 6 | 2017 | 43 | 0.410 |
Why?
| | Glycoproteins | 9 | 2008 | 338 | 0.410 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 54 | 0.410 |
Why?
| | Cell Line | 20 | 2014 | 2780 | 0.390 |
Why?
| | Neoplasms | 6 | 2017 | 2454 | 0.380 |
Why?
| | Cell Proliferation | 11 | 2024 | 2378 | 0.380 |
Why?
| | Stem Cells | 3 | 2020 | 578 | 0.380 |
Why?
| | Radiology | 1 | 2014 | 159 | 0.370 |
Why?
| | Protein Processing, Post-Translational | 8 | 2007 | 457 | 0.370 |
Why?
| | Gene Targeting | 1 | 2010 | 81 | 0.340 |
Why?
| | Intestine, Small | 3 | 2025 | 151 | 0.330 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 48 | 0.320 |
Why?
| | Tamoxifen | 1 | 2010 | 197 | 0.320 |
Why?
| | Mice, Knockout | 12 | 2015 | 2888 | 0.320 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2024 | 269 | 0.320 |
Why?
| | Mass Screening | 5 | 2009 | 1192 | 0.320 |
Why?
| | Cell Polarity | 6 | 2003 | 139 | 0.300 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.300 |
Why?
| | Inflammation | 5 | 2019 | 2748 | 0.290 |
Why?
| | Terminology as Topic | 2 | 2007 | 204 | 0.290 |
Why?
| | Stomach | 3 | 2009 | 109 | 0.290 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2008 | 444 | 0.290 |
Why?
| | Thinness | 1 | 2008 | 89 | 0.290 |
Why?
| | Cell Lineage | 3 | 2025 | 332 | 0.280 |
Why?
| | Apoptosis | 10 | 2021 | 2489 | 0.280 |
Why?
| | Homeostasis | 2 | 2021 | 605 | 0.260 |
Why?
| | Humans | 83 | 2024 | 129847 | 0.260 |
Why?
| | Peptide Fragments | 2 | 2010 | 695 | 0.260 |
Why?
| | Hyperplasia | 3 | 2018 | 175 | 0.260 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.250 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 367 | 0.250 |
Why?
| | Transcriptional Activation | 6 | 2013 | 366 | 0.240 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 2057 | 0.240 |
Why?
| | Cell Differentiation | 8 | 2025 | 1900 | 0.230 |
Why?
| | Pancreatic Neoplasms | 2 | 2024 | 879 | 0.230 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 337 | 0.230 |
Why?
| | Dogs | 8 | 2011 | 385 | 0.220 |
Why?
| | Angiotensin II | 4 | 2008 | 95 | 0.220 |
Why?
| | Allyl Compounds | 2 | 2022 | 21 | 0.220 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5468 | 0.210 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 844 | 0.210 |
Why?
| | beta Catenin | 2 | 2023 | 224 | 0.210 |
Why?
| | Sulfides | 2 | 2022 | 95 | 0.210 |
Why?
| | Energy Metabolism | 1 | 2008 | 875 | 0.200 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2833 | 0.200 |
Why?
| | Betacellulin | 5 | 2010 | 6 | 0.190 |
Why?
| | Mice, Transgenic | 11 | 2020 | 2135 | 0.190 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 827 | 0.190 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 111 | 0.190 |
Why?
| | Calcium | 5 | 2010 | 1212 | 0.180 |
Why?
| | Ultrasonography | 8 | 2009 | 713 | 0.180 |
Why?
| | Gamma Rays | 1 | 2021 | 54 | 0.170 |
Why?
| | Microscopy | 1 | 2022 | 140 | 0.170 |
Why?
| | Cell Movement | 5 | 2021 | 950 | 0.170 |
Why?
| | Taste Buds | 1 | 2023 | 206 | 0.170 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 19 | 0.170 |
Why?
| | Female | 40 | 2021 | 68829 | 0.170 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1690 | 0.170 |
Why?
| | Colitis | 2 | 2019 | 245 | 0.160 |
Why?
| | Photolysis | 1 | 2020 | 90 | 0.160 |
Why?
| | Radiation Injuries | 1 | 2021 | 135 | 0.160 |
Why?
| | Doxorubicin | 3 | 2018 | 329 | 0.160 |
Why?
| | Antiporters | 1 | 2019 | 22 | 0.160 |
Why?
| | Histones | 1 | 2025 | 588 | 0.160 |
Why?
| | Cell Survival | 2 | 2014 | 1086 | 0.160 |
Why?
| | Gastric Mucosa | 7 | 2009 | 53 | 0.160 |
Why?
| | History, 21st Century | 2 | 2014 | 186 | 0.160 |
Why?
| | Cells, Cultured | 17 | 2019 | 4102 | 0.160 |
Why?
| | Colon | 3 | 2017 | 257 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 201 | 0.150 |
Why?
| | Gene Deletion | 2 | 2018 | 380 | 0.150 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 20 | 0.150 |
Why?
| | Cell Dedifferentiation | 1 | 2018 | 30 | 0.150 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 19 | 0.150 |
Why?
| | History, 20th Century | 2 | 2014 | 295 | 0.150 |
Why?
| | Acidosis | 1 | 2019 | 89 | 0.150 |
Why?
| | Mitosis | 2 | 2018 | 180 | 0.150 |
Why?
| | Protease Inhibitors | 4 | 2012 | 107 | 0.150 |
Why?
| | Clone Cells | 1 | 2018 | 262 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 526 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 187 | 0.150 |
Why?
| | Leptin | 2 | 2010 | 222 | 0.150 |
Why?
| | Atrophy | 2 | 2015 | 170 | 0.140 |
Why?
| | Ligands | 8 | 2022 | 621 | 0.140 |
Why?
| | T-Lymphocytes | 4 | 2013 | 1937 | 0.140 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 68 | 0.140 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 40 | 0.140 |
Why?
| | EGF Family of Proteins | 7 | 2008 | 16 | 0.140 |
Why?
| | Amphiregulin | 7 | 2008 | 24 | 0.140 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 194 | 0.140 |
Why?
| | Goblet Cells | 2 | 2014 | 22 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 2045 | 0.140 |
Why?
| | Keratinocytes | 6 | 2010 | 244 | 0.130 |
Why?
| | Hydrogels | 2 | 2022 | 646 | 0.130 |
Why?
| | Neutrophils | 2 | 2019 | 1209 | 0.130 |
Why?
| | Kidney | 5 | 2001 | 1383 | 0.130 |
Why?
| | Adenoma | 1 | 2018 | 213 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2022 | 749 | 0.130 |
Why?
| | Base Sequence | 6 | 2011 | 2142 | 0.130 |
Why?
| | Cytokines | 2 | 2015 | 2022 | 0.130 |
Why?
| | Receptor, ErbB-2 | 3 | 2007 | 325 | 0.130 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2545 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 259 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 707 | 0.120 |
Why?
| | Alleles | 1 | 2018 | 843 | 0.120 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1847 | 0.120 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 2 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3397 | 0.120 |
Why?
| | Transfection | 7 | 2006 | 918 | 0.120 |
Why?
| | Time Factors | 6 | 2014 | 6550 | 0.120 |
Why?
| | Antibodies, Monoclonal | 7 | 2000 | 1368 | 0.120 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 109 | 0.120 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 62 | 0.120 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 15 | 0.120 |
Why?
| | Hydrolysis | 5 | 2010 | 186 | 0.110 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 61 | 0.110 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 6 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 954 | 0.110 |
Why?
| | Phenotype | 4 | 2014 | 3062 | 0.110 |
Why?
| | Kinetics | 5 | 2005 | 1645 | 0.110 |
Why?
| | B-Lymphocytes | 3 | 2010 | 816 | 0.110 |
Why?
| | Lateral Ventricles | 1 | 2014 | 36 | 0.110 |
Why?
| | Solubility | 3 | 2020 | 232 | 0.110 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1282 | 0.110 |
Why?
| | Anesthesia, Local | 1 | 1993 | 16 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2018 | 724 | 0.110 |
Why?
| | ROC Curve | 4 | 2008 | 504 | 0.110 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 3185 | 0.100 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.100 |
Why?
| | Cell Division | 8 | 2004 | 790 | 0.100 |
Why?
| | Cell Nucleus | 3 | 2018 | 590 | 0.100 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.100 |
Why?
| | Probiotics | 1 | 2013 | 51 | 0.100 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 931 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1434 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 264 | 0.100 |
Why?
| | Cadherins | 1 | 2014 | 190 | 0.100 |
Why?
| | CD3 Complex | 1 | 2013 | 102 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2014 | 142 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 326 | 0.100 |
Why?
| | Protein Kinase C | 4 | 2003 | 262 | 0.100 |
Why?
| | Skin | 3 | 2010 | 725 | 0.100 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 130 | 0.090 |
Why?
| | Reproducibility of Results | 5 | 2020 | 3089 | 0.090 |
Why?
| | Blotting, Western | 4 | 2008 | 1204 | 0.090 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 44 | 0.090 |
Why?
| | Genes, ras | 3 | 1998 | 95 | 0.090 |
Why?
| | Cytoplasm | 2 | 2003 | 269 | 0.090 |
Why?
| | Macrophages | 2 | 2017 | 1489 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 67 | 0.090 |
Why?
| | Extracellular Matrix | 3 | 2022 | 508 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 298 | 0.090 |
Why?
| | Galactosides | 1 | 2010 | 4 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 443 | 0.090 |
Why?
| | Presenilin-2 | 1 | 2010 | 4 | 0.090 |
Why?
| | Protein Transport | 2 | 2003 | 429 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 46 | 0.090 |
Why?
| | Crosses, Genetic | 1 | 2010 | 134 | 0.090 |
Why?
| | Presenilin-1 | 1 | 2010 | 31 | 0.090 |
Why?
| | Lipoylation | 1 | 2010 | 17 | 0.090 |
Why?
| | Recovery of Function | 1 | 2014 | 645 | 0.080 |
Why?
| | Peptides | 1 | 1995 | 926 | 0.080 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 317 | 0.080 |
Why?
| | Receptors, IgE | 1 | 2010 | 44 | 0.080 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 37 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2010 | 266 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 808 | 0.080 |
Why?
| | Hair | 1 | 2010 | 73 | 0.080 |
Why?
| | Paclitaxel | 3 | 2024 | 218 | 0.080 |
Why?
| | Male | 15 | 2017 | 63759 | 0.080 |
Why?
| | Radiography | 3 | 2014 | 800 | 0.080 |
Why?
| | Antigens, CD | 3 | 2007 | 487 | 0.080 |
Why?
| | Calcinosis | 2 | 2006 | 233 | 0.080 |
Why?
| | DNA, Complementary | 3 | 2010 | 266 | 0.080 |
Why?
| | Mutagenesis | 2 | 2001 | 179 | 0.080 |
Why?
| | Adult | 16 | 2010 | 35634 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2009 | 29 | 0.080 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 15 | 0.080 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 13 | 0.080 |
Why?
| | Fats | 1 | 2008 | 14 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2010 | 851 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1327 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 313 | 0.070 |
Why?
| | Disintegrins | 2 | 2007 | 5 | 0.070 |
Why?
| | Hydroxamic Acids | 3 | 2006 | 88 | 0.070 |
Why?
| | Swine | 1 | 2010 | 761 | 0.070 |
Why?
| | Enzyme Precursors | 1 | 2007 | 14 | 0.070 |
Why?
| | Ion Channels | 1 | 2008 | 133 | 0.070 |
Why?
| | Isoenzymes | 2 | 2000 | 301 | 0.070 |
Why?
| | HEK293 Cells | 3 | 2017 | 697 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 207 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 38 | 0.070 |
Why?
| | Hypothalamus | 1 | 2008 | 148 | 0.070 |
Why?
| | Middle Aged | 14 | 2007 | 31177 | 0.070 |
Why?
| | Intercellular Junctions | 2 | 2000 | 39 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2013 | 1110 | 0.070 |
Why?
| | Efficiency | 1 | 2008 | 92 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2013 | 838 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1560 | 0.070 |
Why?
| | Observer Variation | 1 | 2008 | 314 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 118 | 0.070 |
Why?
| | Adipocytes | 1 | 2008 | 205 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 319 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2019 | 4077 | 0.070 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 15 | 0.060 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 371 | 0.060 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 748 | 0.060 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 44 | 0.060 |
Why?
| | Phosphorylation | 6 | 2013 | 1716 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 247 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 252 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 139 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2004 | 312 | 0.060 |
Why?
| | United States | 3 | 2014 | 13913 | 0.060 |
Why?
| | Tyrosine | 3 | 2008 | 223 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 99 | 0.060 |
Why?
| | Eating | 1 | 2008 | 372 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 9 | 0.060 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 341 | 0.060 |
Why?
| | Fibromatosis, Aggressive | 1 | 2005 | 17 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2010 | 1311 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 836 | 0.060 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.060 |
Why?
| | RNA, Messenger | 7 | 2018 | 2703 | 0.060 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 121 | 0.060 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 241 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 180 | 0.060 |
Why?
| | Rats | 9 | 2008 | 5487 | 0.060 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 155 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 422 | 0.060 |
Why?
| | Biological Transport | 3 | 2008 | 405 | 0.060 |
Why?
| | Ion Transport | 1 | 2004 | 62 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 377 | 0.060 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 158 | 0.060 |
Why?
| | Gastric Acid | 2 | 1995 | 14 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 234 | 0.060 |
Why?
| | Methylation | 1 | 2025 | 228 | 0.060 |
Why?
| | Mice, Nude | 2 | 2024 | 680 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2004 | 70 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 836 | 0.050 |
Why?
| | Enzyme Activation | 4 | 2013 | 813 | 0.050 |
Why?
| | Neurons | 1 | 2012 | 1509 | 0.050 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 26 | 0.050 |
Why?
| | Motor Activity | 1 | 2008 | 684 | 0.050 |
Why?
| | DNA Primers | 1 | 2004 | 508 | 0.050 |
Why?
| | Heparin | 1 | 2005 | 254 | 0.050 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 37 | 0.050 |
Why?
| | Mutation | 5 | 2010 | 3706 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 231 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 739 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2024 | 164 | 0.050 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 128 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 216 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 215 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 78 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 109 | 0.050 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2002 | 15 | 0.050 |
Why?
| | Molecular Weight | 2 | 1997 | 330 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 381 | 0.050 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 100 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 108 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 170 | 0.050 |
Why?
| | Aged | 8 | 2007 | 22107 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 211 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 317 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 311 | 0.050 |
Why?
| | Morphogenesis | 1 | 2023 | 158 | 0.050 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.050 |
Why?
| | Chemokines, CX3C | 1 | 2001 | 11 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 188 | 0.050 |
Why?
| | Milk Proteins | 2 | 1995 | 34 | 0.050 |
Why?
| | Prevalence | 1 | 2008 | 2564 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 364 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 3773 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 741 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 50 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2001 | 179 | 0.040 |
Why?
| | Phenylalanine | 2 | 1998 | 65 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2004 | 98 | 0.040 |
Why?
| | Brain | 2 | 2010 | 2677 | 0.040 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 10 | 0.040 |
Why?
| | Quinazolines | 2 | 2015 | 243 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1981 | 103 | 0.040 |
Why?
| | Brain Diseases | 1 | 1981 | 134 | 0.040 |
Why?
| | Shear Strength | 1 | 2020 | 67 | 0.040 |
Why?
| | Thiophenes | 2 | 1998 | 117 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2000 | 88 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 297 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 944 | 0.040 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 10 | 0.040 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 22 | 0.040 |
Why?
| | Fetal Diseases | 1 | 1981 | 164 | 0.040 |
Why?
| | Insulin | 1 | 2010 | 2330 | 0.040 |
Why?
| | Rheology | 1 | 2020 | 91 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 30 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 196 | 0.040 |
Why?
| | Fibroblasts | 2 | 2002 | 954 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 34 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 213 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 431 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 80 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 634 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 16 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 42 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 434 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 213 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 48 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 14 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 70 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 151 | 0.040 |
Why?
| | Pain | 2 | 1993 | 791 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2007 | 7066 | 0.040 |
Why?
| | Mucin-2 | 1 | 2017 | 2 | 0.040 |
Why?
| | Adenosine | 1 | 2019 | 227 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 404 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 139 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 84 | 0.040 |
Why?
| | Glycosylation | 1 | 1998 | 153 | 0.040 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 30 | 0.040 |
Why?
| | Cell Adhesion | 3 | 2014 | 455 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 108 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2000 | 333 | 0.040 |
Why?
| | Light | 1 | 2020 | 363 | 0.030 |
Why?
| | Retrospective Studies | 5 | 2007 | 14553 | 0.030 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 22 | 0.030 |
Why?
| | Dipeptides | 2 | 2008 | 48 | 0.030 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 1951 | 0.030 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.030 |
Why?
| | Extracellular Space | 1 | 1997 | 120 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5085 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 67 | 0.030 |
Why?
| | Graft Rejection | 1 | 2000 | 598 | 0.030 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 72 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 287 | 0.030 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1416 | 0.030 |
Why?
| | Hypertrophy | 2 | 2008 | 125 | 0.030 |
Why?
| | Prostaglandins | 1 | 1997 | 94 | 0.030 |
Why?
| | Models, Biological | 2 | 2020 | 1724 | 0.030 |
Why?
| | Spleen | 2 | 2010 | 508 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1872 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 186 | 0.030 |
Why?
| | Foreign Bodies | 1 | 1997 | 103 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 191 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 104 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 484 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 155 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 521 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 207 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 280 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 234 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 5437 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 610 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 462 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 197 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 404 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 306 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 76 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 94 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 108 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 55 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 4 | 2003 | 2403 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 65 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 722 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 1058 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 43 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 13 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 44 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 3161 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 65 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 109 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 84 | 0.030 |
Why?
| | Lidocaine | 1 | 1993 | 41 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1465 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 40 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 1993 | 30 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 169 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 146 | 0.030 |
Why?
| | Mitogens | 1 | 1993 | 61 | 0.030 |
Why?
| | Adenoviridae | 2 | 2005 | 193 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 2 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 524 | 0.030 |
Why?
| | Metallothionein | 1 | 1992 | 25 | 0.030 |
Why?
| | Risk Factors | 4 | 2010 | 9801 | 0.030 |
Why?
| | Stomach Diseases | 1 | 1992 | 20 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 1993 | 121 | 0.030 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 27 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 2003 | 149 | 0.020 |
Why?
| | Keratins | 1 | 1993 | 175 | 0.020 |
Why?
| | Antigens | 1 | 2014 | 356 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1033 | 0.020 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 44 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 284 | 0.020 |
Why?
| | Contrast Media | 1 | 1975 | 394 | 0.020 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.020 |
Why?
| | Retroviridae | 2 | 2005 | 96 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1977 | 494 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 129 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 773 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 337 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 22 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 131 | 0.020 |
Why?
| | Pregnancy | 3 | 1995 | 6423 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 30 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 493 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 116 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 4 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 641 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 63 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 235 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 399 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 140 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 202 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 103 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 165 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 338 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 147 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 439 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 55 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 33 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 190 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 38 | 0.020 |
Why?
| | Exons | 1 | 2010 | 341 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 371 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 175 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 17 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1406 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 55 | 0.020 |
Why?
| | Epitopes | 2 | 1990 | 474 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 83 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 19 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 244 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1058 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 88 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 232 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 46 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 830 | 0.020 |
Why?
| | Laminin | 1 | 1987 | 68 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 120 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 95 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1248 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1213 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 893 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 107 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 49 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 127 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 15 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 320 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 6 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 393 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 80 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 113 | 0.020 |
Why?
| | Artifacts | 1 | 2006 | 127 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1986 | 152 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 130 | 0.020 |
Why?
| | Binding Sites | 2 | 2005 | 1251 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 277 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1092 | 0.020 |
Why?
| | Organ Specificity | 1 | 1986 | 295 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 137 | 0.020 |
Why?
| | Specimen Handling | 1 | 2006 | 163 | 0.020 |
Why?
| | Ionophores | 1 | 2005 | 23 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2006 | 146 | 0.020 |
Why?
| | Lac Operon | 1 | 2005 | 46 | 0.010 |
Why?
| | Guanylate Kinases | 1 | 2005 | 13 | 0.010 |
Why?
| | Aorta | 1 | 2008 | 408 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 2005 | 74 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 55 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 778 | 0.010 |
Why?
| | Liver | 1 | 1993 | 1839 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 2016 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 422 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4896 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1996 | 157 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 147 | 0.010 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.010 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 21 | 0.010 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 110 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 92 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 32 | 0.010 |
Why?
| | RNA | 1 | 2010 | 877 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 13 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 379 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 31 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 382 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 25 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 312 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1995 | 73 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 175 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 312 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 592 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 650 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 17 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 782 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 590 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2001 | 23 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 27 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 48 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 87 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 33 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 48 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 55 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 112 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 38 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 121 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 60 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 202 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 21 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 4 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 161 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 53 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 37 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 201 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 277 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 402 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 147 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 331 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 155 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1686 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 10 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 200 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 29 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 1031 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 25 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2123 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 54 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 6 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 6 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 82 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 80 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 48 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 88 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 80 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 385 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 477 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 32 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 371 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 69 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 400 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 225 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 21 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1160 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 27 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 16 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 17 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 13 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 165 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 15 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 80 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 21 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 52 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 82 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 80 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1774 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 176 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 10 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 206 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 11 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 20451 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 583 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 316 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 2 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 19 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 5 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 48 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 23 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 12 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 23 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 24 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 141 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 196 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 94 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1724 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 541 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 105 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 85 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 24 | 0.010 |
Why?
| | Head | 1 | 1975 | 96 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 175 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 13 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 48 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 49 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 126 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 196 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 403 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 167 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1441 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 36 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 497 | 0.010 |
Why?
| | Movement | 1 | 1975 | 270 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 318 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 6 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 9 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 28 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 310 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 42 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 834 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 212 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 368 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 188 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 425 | 0.010 |
Why?
| | Child | 1 | 2010 | 20962 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 74 | 0.010 |
Why?
| | Piperazines | 1 | 1992 | 339 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 85 | 0.010 |
Why?
| | Disulfides | 1 | 1990 | 97 | 0.000 |
Why?
| | Adenine Nucleotides | 1 | 1968 | 22 | 0.000 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 1968 | 53 | 0.000 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1990 | 585 | 0.000 |
Why?
| | Myocardium | 1 | 1968 | 983 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 34 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1089 | 0.000 |
Why?
| | Denervation | 1 | 1968 | 22 | 0.000 |
Why?
| | Tritium | 1 | 1968 | 75 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1968 | 83 | 0.000 |
Why?
| | Cats | 1 | 1968 | 207 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1968 | 238 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|